




CONCLUSIONS AND SUGGESTIONS 
5.1 Conclusions 
 Based on the hypothesis testing that has been done, it can be 
concluded that the research results are as follows: 
1. There is a significant difference in average abnormal return before and 
after the initial vaccine COVID-19 in Indonesia. This can be shown from 
the results of statistical processing with a significance value of 0.015 < 
0.05. Thus H1 is accepted. 
2. There is no significant difference in average trading volume activity before 
and after the initial injection of COVID-19 in Indonesia. This can be shown 
from the results of statistical processing with a significance value of 0.113 
> 0.05. Thus H2 is rejected. 
3. There is a significant difference in the average bid-ask spread before and 
after the initial vaccine COVID-19 in Indonesia. This can be shown from 
the result of statistical processing with a significance value of 0.001 < 0.05. 
Thus H3 is accepted. 
4. The conclusion in this study can be said that the initial injection of the 
COVID-19 vaccine contains information on stocks listed on the Indonesia 




information on investor reactions in terms of falling stock prices which 
have an impact on abnormal returns and bid-ask spreads. 
5.2 Research Implication 
1. Theoretical Implication 
 This study adds empirical evidence that abnormal returns and bid-ask 
spreads significantly affect companies listed on the IDXHEALTH index and 
companies with subsidiaries engaged in the health sector. Moreover, this study 
also provides evidence that the vaccine injection event reduces trading volume 
activity on the stock market, indicating that investors lack confidence in the 
company's performance, resulting in lower stock prices. So, it is hoped that in 
the future, many parties will consider these shares to be an option in 
conducting trading transactions if the event is related to health issues. 
2. Managerial Implication 
 The company is expected to pay attention to its involvement in 
increasing investor demand to realize its strategy and presence in the market. 
This research information can provide a signal to investors to take advantage 
of current events to attract investors' attention to trade transactions. So, in the 
future the company is expected to be able to provide good information in 
order to keep investors investing in the company so that the company can 
survive due to crisis. 
3. Investor Implication 




information, especially the initial injection of vaccine COVID-19, gives a 
signal to investors about how they should react to information in the capital 
market. The results of the study show that the presence of abnormal returns 
and bid-ask spreads has an effect on an event, so investors are expected to pay 
attention to stock price movements to get profits. 
4. For Further Research 
 Further research can increase the population, add research variables, 
increase the number of samples, and use different calculation methods so that 
future researchers can research with better results. 
5.3 Research Limitation 
 This research has been carried out with the best and full of accuracy. 
However, there are some limitations in this study that should be noted: 
1. The event window of the research is relatively short, which is 10 (ten) 
days before and 10 (ten) days after the initial injection of vaccine 
COVID-19 in Indonesia. Meanwhile, until the completion of this research 
as of July 2021, information related to the vaccine of COVID-19 impacts 
investors' decisions to trade so that the selection of different research 
periods may produce different research results. 
2. There are only 3 (three) market reaction proxies used in this study: AAR, 
TVA, and bid-ask spread. This study only measures abnormal returns 




3. The sample in this study is only 30 samples because very few companies 
are listed on IDXHEALTH, and companies have subsidiaries related to 
health and pharmaceuticals. 
5.4 Suggestion  
 From the results of the research concluded earlier, there are several 
suggestions as follows: 
1. For Managerial 
 In the study results, there are significant differences in abnormal 
returns and bid-ask spreads before and after the initial injection of the 
COVID-19 vaccine. Therefore, it is hoped that the managerial side will give 
an effort in the vaccine production line by enhancing the quality of vaccine, 
the distribution to the society, to maintain the contract, expand the business 
area, and ensuring the effectiveness of the vaccine to keep the trust of the 
customer and society. Hence, the stock prices of the company will keep stable, 
even increase continuously. 
2. For investor 
 The existence of significant differences in abnormal returns and bid-
ask spreads is expected to be a good signal for traders who want to make 
profits in a short time so that traders can quickly analyze this vital 
information. 
 As for investors, it is hoped that they will not be in a hurry to get out 
of the capital market because of the quite volatile situation when there is 




information is positive, it is hoped that investors will be able to maintain their 
investment.  
 Investors are advised to be careful with information circulating in the 
market and consider it in making investment decisions to minimize risk. 
Investors should be cautious in choosing stocks that can provide a higher rate 
of return than the market benchmark. 
3. For Further Researcher 
 It is recommended for the next researcher to further develop this 
research with the number of samples by using another population so that 
future researchers will get better results than representing the actual situation. 
 Then, it is recommended for the next researcher to further develop this 
research with other methods such as Capital Asset Pricing Model (CAPM) or 
Mean Adjusted Model may produce different research results and make 
comparisons for each method so that it can be known whether there are 
differences in the research results. 
  Hopefully, the next research can provide a more significant 
contribution to this topic. It is hoped that this research can be a help for further 
researchers and a source of reference. 
